|
research
| Date |
Article Rating |
Type |
Title |
|
Dec 03, 2003 |
 |
Article |
"You're my Wife?" Amnesia is Possible Side Effect of Statin Drug
One day former astronaut Duane Graveline came back from a walk and failed to recognise his wife. He blamed this temporary bout of amnesia on the drug Lipitor, which he had been taking for several weeks. |
|
Oct 17, 2003 |
|
Article,DrugNews |
FDA Approves Alzheimer's Drug: Memantine
Memantine is first prescription drug approved for late stages of Alzheimer's disease. |
|
Jun 07, 2005 |
|
Article |
Potential for Reducing the Progression of Alzheimer's Revealed
University of Florida researchers have discovered a way to reduce plaque deposits on the brain that could slow the progression of Alzheimer's disease. |
|
Nov 06, 2002 |
|
Article |
Seeing Into the Alzheimer’s Brain: PET Scans, Diagnosis & Treatment
Even though Alzheimer's disease takes a terrible toll on the memories and lives of millions of adults each year, doctors often face great uncertainty when trying to diagnose it in living people. A good new diagnostic test could help patients get help early and make the most of their remaining years, is needed. That's why University of Michigan Health System researchers and others are so excited about a kind of medical imaging that they think can tell Alzheimer's disease apart from other disorders.
|
|
Sep 11, 2002 |
|
Article |
New Study Reports Positive Results for New Alzheimer’s Treatment Memantine
researchers from Forest Laboratories Inc., announced that in a recently completed 6 month placebo-controlled study of patients with moderate-to-severe Alzheimer's disease, a significant benefit was observed when memantine treatment was added to their background donepezil (Aricept®) therapeutic regimen.
|
|
May 10, 2004 |
|
Article |
researchers Find Novel Method of Distinguishing Alzheimer's From Other Types of Dementia
Nearly a century after Alzheimer's disease was first identified, there has been no foolproof way to diagnose the illness in a living patient. But a new method used by doctors at UT Southwestern Medical Center at Dallas is almost 100 percent accurate when combined with clinical assessment. |
|
Nov 10, 2003 |
|
Article |
PET Scan Predicts Alzheimer's More Accurately
Scanning a patient's brain metabolism with positron-emission tomography (PET) can improve a doctor's ability to forecast the patient's future cognitive functions by up to 30 percent, a new UCLA study discovered. |
|
Sep 25, 2003 |
|
Article,DrugNews |
FDA Backs New Alzheimer’s Drug: Memantine
A drug long used in Germany to ease the ravages of Alzheimer’s disease took a step toward the U.S. market on Wednesday when government scientists backed memantine as the first treatment specifically for late stages of the mind-stealing disease. |
|
Apr 21, 2003 |
|
Article |
Cholesterol Lowering Drugs Shown to Decrease Predictor of Alzheimer's Disease
Cholesterol-lowering medications known as statins also play an important role in reducing levels of a strong predictor of Alzheimer's disease, according to a new study from UT Southwestern Medical Center at Dallas researchers. |
|
Mar 05, 2003 |
|
Article |
Ginkgo Biloba research Shows Promising Evidence for Alzheimer's Disease
The Alzheimer's Society, together with the Cochrane Collaboration, has published the largest comprehensive review on the use of Ginkgo biloba for the treatment of dementia. This new research provides promising evidence that taking Ginkgo biloba can improve memory and overall function for people with dementia.
|
|
|
Next 10 Articles>> |
|
|
|
